MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

Orthofix International NV

Fermé

SecteurSoins de santé

15.09 -1.57

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.04

Max

15.31

Chiffres clés

By Trading Economics

Revenu

-8.7M

-23M

Ventes

2.5M

206M

BPA

0.198

Marge bénéficiaire

-11.085

Employés

1,616

EBITDA

-11M

-3.1M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+39.14% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-21M

613M

Ouverture précédente

16.66

Clôture précédente

15.09

Sentiment de l'Actualité

By Acuity

50%

50%

157 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Orthofix International NV Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 déc. 2025, 22:20 UTC

Principaux Mouvements du Marché

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 déc. 2025, 17:31 UTC

Principaux Mouvements du Marché

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 déc. 2025, 16:30 UTC

Principaux Mouvements du Marché

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 déc. 2025, 15:19 UTC

Principaux Mouvements du Marché

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 déc. 2025, 15:17 UTC

Principaux Mouvements du Marché

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 déc. 2025, 14:37 UTC

Principaux Mouvements du Marché

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 déc. 2025, 21:13 UTC

Acquisitions, Fusions, Rachats

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 déc. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 déc. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 déc. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 déc. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 déc. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 déc. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 déc. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 déc. 2025, 17:16 UTC

Principaux Mouvements du Marché

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 déc. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 déc. 2025, 17:00 UTC

Acquisitions, Fusions, Rachats

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 déc. 2025, 15:57 UTC

Acquisitions, Fusions, Rachats

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 déc. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 déc. 2025, 15:02 UTC

Principaux Mouvements du Marché

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 déc. 2025, 14:40 UTC

Acquisitions, Fusions, Rachats

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 déc. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 déc. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 déc. 2025, 13:01 UTC

Résultats
Acquisitions, Fusions, Rachats

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 déc. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 déc. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 déc. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 déc. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 déc. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparaison

Variation de prix

Orthofix International NV prévision

Objectif de Prix

By TipRanks

39.14% hausse

Prévisions sur 12 Mois

Moyen 21.33 USD  39.14%

Haut 24 USD

Bas 18 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

3

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

10.4 / 12.1Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

157 / 374Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Orthofix International NV

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
help-icon Live chat